These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16938119)

  • 1. Impaired megakaryopoiesis in patients with chronic idiopathic neutropenia is associated with increased transforming growth factor beta1 production in the bone marrow.
    Psyllaki M; Damianaki A; Gemetzi C; Pyrovolaki K; Eliopoulos GD; Papadaki HA
    Br J Haematol; 2006 Sep; 134(6):624-31. PubMed ID: 16938119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta1 affects interleukin-10 production in the bone marrow of patients with chronic idiopathic neutropenia.
    Pyrovolaki K; Mavroudi I; Papadantonakis N; Velegraki M; Ximeri M; Kalpadakis C; Gvazava G; Klaus M; Eliopoulos GD; Papadaki HA
    Eur J Haematol; 2007 Dec; 79(6):531-8. PubMed ID: 17961177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-inflammatory bone marrow milieu in patients with chronic idiopathic neutropenia is associated with impaired local production of interleukin-10.
    Koumaki V; Damianaki A; Ximeri M; Pontikoglou C; Axioti F; Spanoudakis M; Eliopoulos GD; Papadaki HA
    Br J Haematol; 2006 Nov; 135(4):570-3. PubMed ID: 17054669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia.
    Pontikoglou C; Liapakis G; Pyrovolaki K; Papadakis M; Bux J; Eliopoulos GD; Papadaki HA
    Exp Hematol; 2006 Oct; 34(10):1312-22. PubMed ID: 16982324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells contribute to the abnormal bone marrow microenvironment in patients with chronic idiopathic neutropenia by overproduction of transforming growth factor-β1.
    Stavroulaki E; Kastrinaki MC; Pontikoglou C; Eliopoulos D; Damianaki A; Mavroudi I; Pyrovolaki K; Katonis P; Papadaki HA
    Stem Cells Dev; 2011 Aug; 20(8):1309-18. PubMed ID: 21047210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
    Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
    Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia.
    Papadaki HA; Stamatopoulos K; Damianaki A; Gemetzi C; Anagnostopoulos A; Papadaki T; Eliopoulos AG; Eliopoulos GD
    Br J Haematol; 2005 Mar; 128(6):863-76. PubMed ID: 15755293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombopoietin concentrations in peripheral blood correlated with platelet numbers in two patients with thrombocytopenia by chronic graft-versus-host disease.
    Hirayama Y; Sakamaki S; Tsuji Y; Sagawa T; Chiba H; Matsunaga T; Kuroda H; Kusakabe T; Akiyama T; Kato J; Niitsu Y
    Am J Hematol; 2003 Aug; 73(4):285-9. PubMed ID: 12879435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia.
    Kuwana M; Okazaki Y; Kajihara M; Kaburaki J; Miyazaki H; Kawakami Y; Ikeda Y
    Arthritis Rheum; 2002 Aug; 46(8):2148-59. PubMed ID: 12209520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis.
    Pyrovolaki K; Mavroudi I; Sidiropoulos P; Eliopoulos AG; Boumpas DT; Papadaki HA
    Arthritis Rheum; 2009 Feb; 60(2):543-52. PubMed ID: 19180486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of soluble flt-3 ligand in serum and long-term bone marrow culture supernatants in patients with chronic idiopathic neutropenia.
    Papadaki HA; Damianaki A; Pontikoglou C; Pyrovolaki K; Eliopoulos DG; Stavroulaki E; Eliopoulos GD
    Br J Haematol; 2006 Mar; 132(5):637-9. PubMed ID: 16445839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of erythroid, megakaryocyte and myeloid hematopoietic support function with neutralizing antibodies against IL-4 and TGFbeta1 in long-term bone marrow cultures infected with LP-BM5 murine leukemia virus.
    Tse KF; Inayat MS; Morrow JK; Hughes NK; Oakley OR; Gallicchio VS
    Virus Res; 2005 Oct; 113(1):1-15. PubMed ID: 15869820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the bioactive and total transforming growth factor β1 levels in primary myelofibrosis.
    Campanelli R; Rosti V; Villani L; Castagno M; Moretti E; Bonetti E; Bergamaschi G; Balduini A; Barosi G; Massa M
    Cytokine; 2011 Jan; 53(1):100-6. PubMed ID: 20801055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replication.
    Costantini A; Giuliodoro S; Mancini S; Butini L; Regnery CM; Silvestri G; Greco F; Leoni P; Montroni M
    AIDS; 2006 Aug; 20(13):1713-20. PubMed ID: 16931935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cell apoptosis in bone marrow trephine biopsies and immunomagnetically isolated myeloid progenitor cells in patients with chronic idiopathic neutropenia.
    Koumaki V; Papadaki HA; Stefanaki K; Damianaki A; Gemetzi C; Katonis P; Vrentzos G; Eliopoulos GD
    Ann Hematol; 2003 Oct; 82(10):641-5. PubMed ID: 12904900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta-1 and gene polymorphisms in oriental ankylosing spondylitis.
    Howe HS; Cheung PL; Kong KO; Badsha H; Thong BY; Leong KP; Koh ET; Lian TY; Cheng YK; Lam S; Teo D; Lau TC; Leung BP
    Rheumatology (Oxford); 2005 Jan; 44(1):51-4. PubMed ID: 15479754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis.
    Fukushima-Shintani M; Suzuki K; Iwatsuki Y; Abe M; Sugasawa K; Hirayama F; Kawasaki T
    Exp Hematol; 2008 Oct; 36(10):1337-42. PubMed ID: 18619724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro response of myelodysplastic megakaryocytopoiesis to megakaryocyte growth and development factor (MGDF).
    Faulhaber M; Wörmann B; Ganser A; Verbeek W
    Ann Hematol; 2002 Dec; 81(12):695-700. PubMed ID: 12483365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel serum free system for cloning human megakaryocytic progenitors (CFU-Meg). The role of thrombopoietin and other cytokines on bone marrow and cord blood CFU-Meg growth under serum free conditions.
    Ratajczak J; Machaliński B; Samuel A; Pertusini E; Majka M; Czajka R; Ratajczak MZ
    Folia Histochem Cytobiol; 1998; 36(2):61-6. PubMed ID: 9606619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
    Akiyama T; Matsunaga T; Terui T; Miyanishi K; Tanaka I; Sato T; Kuroda H; Takimoto R; Takayama T; Kato J; Yamauchi N; Kogawa K; Sakamaki S; Hirayama Y; Kohda K; Niitsu Y
    Leukemia; 2005 Sep; 19(9):1558-66. PubMed ID: 16034467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.